Published in Drug Law Weekly, April 3rd, 2007
"We welcome the agreement announced," said Pete Wehrly, senior vice president and president of the Spinal and Navigation businesses at Medtronic. "We see OsteoGenix as bringing a new option to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.